medline.ch Dermatologie Tumoren Melanom

	Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study. J Dermatol Ishiguro A, Ogata D, Ishiyama K, Oguma J, Kurita D, Nakano E, Namikawa K, Takahashi A, Daiko H, Seto Y, Yamazaki N. PMID: 41347648 [PubMed - as supplied by publisher]
	Immune checkpoint inhibitors in melanoma: mechanisms, immune cell interactions, and the tumour microenvironment. Front Immunol Liang Y, Zheng Y, Zeng Y, Hu C, Si Y, Fan X, Chen Q. PMID: 41346595 [PubMed - indexed for MEDLINE]
	Clinical Effectiveness and Safety of Electrochemotherapy (ECT) in the Treatment of Locally Advanced Melanoma: A Systematic Review. Cureus Vickars DJ, Mandal A. PMID: 41346423 [PubMed]
	CD33 drives cutaneous melanoma: mendelian randomization confirms causality, multi-omics and in vitro experiments reveal M2 macrophage polarization-mediated progression. Int J Surg Hu L, Wang Y, Liu L, Liu X. PMID: 41346267 [PubMed - as supplied by publisher]
	Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis: a retrospective, multicenter study. Int J Clin Oncol Inoue S, Koizumi S, Yamazaki N, Ichigozaki Y, Kitagawa H, Kiniwa Y, Sato S, Takai T, Doi R, Ito T, Yasuda M, Kuwatsuka Y, Maekawa T, Asai J, Miyagawa T, Matsushita S, Funakoshi T, Yamamoto Y, Inozume T, Kishi A, Takenouchi T, Kokubu H, Ito S, Umeda Y, Yamamoto Y, Ishizuki S, Iino S, Uchi H, Nakagawa T, Inafuku K, Haga T, Kaneko T, Nakagawa M, Kamiya H, Arima M, Hoashi T, Hiura A, Kanazawa N, Manabe K, Ishikawa M, Asagoe K, Iwasawa U, Kadono T, Hatta N, Minami S, Nakano E, Ogata D, Fukushima S, Uhara H, Nakama K, Komori T, Igawa K, Nakamura Y. PMID: 41345808 [PubMed - as supplied by publisher]
	Same mutation, different fates: The Yin-Yang of BRAF-driven therapeutic responses in melanoma and colorectal cancer. Biochim Biophys Acta Rev Cancer Solé-Blanch C, España S, de la Puente-Noël A, Marin-Bejar O, Manzano JL, Martinez-Cardús A. PMID: 41344640 [PubMed - as supplied by publisher]
	Real-World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations. Cancer Med Effiom D, Aprati T, Karneris A, Lawless A, Sharova T, Johnson R, Menzies A, Long G, Park B, Jung S, Johnson D, Liu D, Bai X, Flaherty K, Sullivan R, Boland GM, Cohen S. PMID: 41342263 [PubMed - indexed for MEDLINE]
	A Fatal Case of Metastatic Primary Gastric Melanoma: Diagnostic Challenges and Therapeutic Dilemmas. Cancer Manag Res Zhu X, Ma R, Zheng Q, Si X, Yang G. PMID: 41341014 [PubMed]
	The Melanoma Pathology Report: What to Expect and How to Interpret It. J Dermatol Nirenberg A, Williams R, Steinman H, Anderson S, Dixon A. PMID: 41340017 [PubMed - as supplied by publisher]
	Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis. Target Oncol Saldanha EF, Noronha MM, Reis PCA, Passos PRC, Filho VOC, Cappellaro AP, Almeida LFC, Maselli-Shoueri JH, Lopes CDH, Leite LF, Ribeiro MF, Araujo DV. PMID: 41335285 [PubMed - as supplied by publisher]
	Evaluation of GPA, molGPA and prognostic factors in melanoma brain metastases: a single-center study. Clin Transl Oncol Philippi JC, Mittenbacher N, Vordermark D, Medenwald D, Müller JA. PMID: 41335188 [PubMed - as supplied by publisher]
	Nd: YAG laser in the treatment of non-melanoma and melanoma skin cancers. Lasers Med Sci Abo Zaken G, Moussa MM, Albeik MTMN, Omar A, Almahfoud S. PMID: 41329302 [PubMed - indexed for MEDLINE]
	Advancing melanoma treatment with nanoparticles: from chemotherapy to combination therapies. Nanomedicine (Lond) Hsu CY, Ibrahim Mohammad S, Vasudevan A, Kumar Sharma S, Kareem AK, Klebleeva G, Alrayes ZR, Ahmed AbdRabou M, Jabir MS, Kadhum WR. PMID: 41328565 [PubMed - as supplied by publisher]
	Analysis of content, quality, and reliability of melanoma-related Chinese videos on TikTok: A cross-sectional study. Medicine (Baltimore) Ren L, Li Q, Qin M, Zhao K. PMID: 41327681 [PubMed - indexed for MEDLINE]
	Benign or aggressive? Understanding spinal melanocytomas in comparison to malignant melanoma. J Neurooncol Ryba A, Mohme T, Kerschbaumer J, von Bronewski E, Hubertus V, Butenschoen VM, Kramer A, Stengel FC, Stienen MN, Battistelli M, Polli FM, Meyer HS, Dührsen L, Mende KC, Westphal M, Ringel F, Meyer B, Onken J, Thome C, Eicker SO, Mohme M. PMID: 41324772 [PubMed - indexed for MEDLINE]
	The Value of Detecting and Monitoring ctDNA in Uveal Melanoma: Results of a Pilot Study and a Systematic Review. Case Rep Ophthalmol Azimi F, Talebi S, Mirshahi R, Khakpoor G, Naseripour M. PMID: 41321545 [PubMed]
	How to treat BRAF mutant metastatic melanoma? Per Med Sini MC, Casula M, Pisano M, Palmieri G, Manca A. PMID: 41321021 [PubMed - as supplied by publisher]
	Letter Re: Critical evaluation of sentinel lymph node biopsy in pT1b and pT2a melanoma patients: A nationwide population-based study. Eur J Cancer Varey AH, Lo SN, Thompson JF. PMID: 41319452 [PubMed - as supplied by publisher]
	Response to letter Re: Critical evaluation of sentinel lymph node biopsy in pT1b and pT2a melanoma patients: A nationwide population-based study. Eur J Cancer Schurink AW, Stassen RC, van der Veldt AAM, Grünhagen DJ. PMID: 41319451 [PubMed - as supplied by publisher]
	HyperFusionNet combines vision transformer for early melanoma detection and precise lesion segmentation. Sci Rep Li M, Jiang Y, Cao G, Xu T, Guo R. PMID: 41318765 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 44617

Seite 1 von 2231

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung